ThyroidPrint consists of a genetic signature that analyzes 10 genes in the FNA sample using an algorithm that can predict with 97% certainty whether a node is benign or malignant. This way physicians are able to recommend to patients with benign nodes that they go in for a clinical follow up as an alternative to surgery. The bottom line is that ThyroidPrint will prevent thousands of surgeries and be a tremendous source of relief for those patients.